Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, announced that the U.S. Food and Drug...
Take part in the international conference and exhibition "Ingredients and Additives".In 2022, the event will take place on the territory of Technopark Skolkovo innovation...
The Pharmasyntez Group of companies is going to launch the parenteral (intravenous) nutrition department in Primorye.
At a meeting with Oleg Kozhemyako, Governor of Primorsky...
The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether...
Long-term agreement includes a series of investments to acquire new equipment and adapt the present ROVI drug product fill-finish facilities and production lines in...